Accès ouvert
2025
article
OpenAlex
Josephine Grandt, Christian Dall Johansen, Anne‐Sofie Houlberg Jensen, Mikkel Parsberg Werge et autres
The human liver is dynamic organ with minute to hourly adaptions in response to feeding. Patients with non-alcoholic fatty liver disease (NAFLD) and cirrhosis have altered transcriptomic features compared to controls but how and if food intake affects such is unknown in …
dk
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Anna Billeschou, Christian Dall Johansen, Katrine Douglas Galsgaard, Emilie Elmelund et autres
This study suggests that the glucagon receptor is a potential therapeutic target in the treatment of diabetic kidney disease. We show, in mice, that long-term treatment with a glucagon analog showed not only pathophysiological changes and changes in renal function but also …
dk
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Josephine Grandt, Christian Dall Johansen, Anne‐Sofie Houlberg Jensen, Mikkel Parsberg Werge et autres
Abstract The human liver is dynamic organ with minute to hourly adaptions in response to feeding. Patients with non-alcoholic fatty liver disease (NAFLD) and cirrhosis have altered transcriptomic features compared to controls but how and if food intake affects such is unknown …
dk
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Josephine Grandt, Anne‐Sofie Houlberg Jensen, Mikkel Parsberg Werge, Elias Badal Rashu et autres
Abstract Fatty liver disease has mainly been characterized under fasting conditions. However, as the liver is essential for postprandial homeostasis, identifying postprandial disturbances may be important. Here, we investigated postprandial changes in markers of metabolic dysfunction between healthy individuals, obese individuals with …
dk
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Josephine Grandt, Christian Dall Johansen, Anne‐Sofie Houlberg Jensen, Mikkel Parsberg Werge et autres
dk
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Anna Billeschou, Christian Dall Johansen, Jens Bager Christensen, Sasha A. S. Kjeldsen et autres
Glucagon is a major regulator of metabolism and drugs targeting the glucagon receptor (GCGR) are being developed. Insight into tissue and cell-specific expression of the GCGR is important to understand the biology of glucagon and to differentiate between direct and indirect actions …
dk, es
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Katrine Douglas Galsgaard, Emilie Elmelund, Christian Dall Johansen, Hüsün Sheyma Kizilkaya et autres
OBJECTIVE: Treatment with glucagon receptor antagonists (GRAs) reduces blood glucose but causes dyslipidemia and accumulation of fat in the liver. We investigated the acute and chronic effects of glucagon on lipid metabolism in mice. METHODS: ) mice, and in C57Bl/6JRj mice treated …
dk
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Emilie Elmelund, Katrine Douglas Galsgaard, Christian Dall Johansen, Samuel A.J. Trammell et autres
The pancreatic hormone, glucagon, is known to regulate hepatic glucose production, but recent studies suggest that its regulation of hepatic amino metabolism is equally important. Here, we show that chronic glucagon receptor activation with a long-acting glucagon analog increases amino acid catabolism …
dk
(code pays fourni par la source)
2022
article
OpenAlex
EMILIE E. CHRISTENSEN, Katrine Douglas Galsgaard, Christian Dall Johansen, SAMUEL TRAMMELL et autres
Amino acids control alpha cell secretion and growth, while glucagon stimulates hepatic amino acid uptake and ureagenesis, forming the liver-alpha cell axis. Patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes have increased levels of glucagon and amino acids pointing …
Accès ouvert
2022
preprint
OpenAlex
Emilie Elmelund, Katrine Douglas Galsgaard, Christian Dall Johansen, Samuel A.J. Trammell et autres
dk, gb
(code pays fourni par la source)
Accès ouvert
2021
preprint
OpenAlex
Anna Billeschou, Christian Dall Johansen, Sasha A. S. Kjeldsen, Katrine Douglas Galsgaard et autres
Abstract Glucagon is a key regulator of numerous metabolic functions including glucose, protein and lipid metabolism, and glucagon-based therapies are explored for diabetes, fatty liver disease and obesity. Insight into tissue and cell specific expression of the glucagon receptor (GCGR) is important …
dk, es
(code pays fourni par la source)